Fibulin-3 promotes muscle-invasive bladder cancer

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Oncogene

• Publication date

  2017-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/onc.2017.149PMID 28504717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline.

  2016cited by this paper
• Cancer statistics, 2016

  2016cited by this paper
• Fibulin-3 is a Novel TGF-β pathway Inhibitor in the Breast Cancer Microenvironment

  2015cited by this paper
• Role of fibulin-3 in lung cancer: in vivo and in vitro analyses.

  2014cited by this paper
• Comprehensive molecular characterization of urothelial bladder carcinoma

  2014cited by this paper
• Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.

  2014cited by this paper
• Fibulin-3 suppresses Wnt/β-catenin signaling and lung cancer invasion.

  2014cited by this paper
• Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology

  2014cited by this paper
• Fibulin-3-mediated inhibition of epithelial-to-mesenchymal transition and self-renewal of ALDH+ lung cancer stem cells through IGF1R signaling

  2014cited by this paper
• p38 MAPK Down-regulates Fibulin 3 Expression through Methylation of Gene Regulatory Sequences

  2014cited by this paper
• Novel paracrine modulation of Notch-DLL4 signaling by fibulin-3 promotes angiogenesis in high-grade gliomas.

  2014cited by this paper
• Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential

  2014cited by this paper
• IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder

  2013cited by this paper
• Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal

  2013cited by this paper
• Overexpression of EFEMP1 Correlates with Tumor Progression and Poor Prognosis in Human Ovarian Carcinoma

  2013cited by this paper
• Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation

  2013cited by this paper
• The health economics of bladder cancer

  2012cited by this paper
• Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks

  2012cited by this paper
• A Molecular Taxonomy for Urothelial Carcinoma

  2012cited by this paper
• The Mutational Landscape of Lethal Castrate Resistant Prostate Cancer

  2012cited by this paper
• CDH13 and FLBN3 Gene Methylation are Associated with Poor Prognosis in Colorectal Cancer

  2012cited by this paper
• Fibulin-3 promotes glioma growth and resistance through a novel paracrine regulation of Notch signaling.

  2012cited by this paper
• The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.

  2012cited by this paper
• IGFBP5 induces cell adhesion, increases cell survival and inhibits cell migration in MCF-7 human breast cancer cells

  2012cited by this paper
• Stem cells with fused gene expression of cytosine deaminase and interferon-β migrate to human gastric cancer cells and result in synergistic growth inhibition for potential therapeutic use

  2011cited by this paper
• Downregulation of fibulin-3 gene by promoter methylation in colorectal cancer predicts adverse prognosis.

  2011cited by this paper
• Fibulin-3 promoter methylation alters the invasive behavior of non-small cell lung cancer cell lines via MMP-7 and MMP-2 regulation.

  2011cited by this paper
• EFEMP1 expression promotes angiogenesis and accelerates the growth of cervical cancer in vivo.

  2011cited by this paper
• Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder

  2011cited by this paper
• Fibulin‐3 is associated with tumour progression and a poor prognosis in nasopharyngeal carcinomas and inhibits cell migration and invasion via suppressed AKT activity

  2010cited by this paper
• The expression of EFEMP1 in cervical carcinoma and its relationship with prognosis.

  2010cited by this paper
• Focus on molecules: fibulin-3 (EFEMP1).

  2010cited by this paper
• EFEMP1 Expression Promotes In vivo Tumor Growth in Human Pancreatic Adenocarcinoma

  2009cited by this paper
• ECM1 interacts with fibulin-3 and the beta 3 chain of laminin 332 through its serum albumin subdomain-like 2 domain.

  2009cited by this paper
• Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker

  2009cited by this paper
• Fibulin-3 Is Uniquely Upregulated in Malignant Gliomas and Promotes Tumor Cell Motility and Invasion

  2009cited by this paper
• EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in pancreatic carcinoma cells

  2009cited by this paper
• Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles.

  2007cited by this paper
• Characterization of a panel of cell lines derived from urothelial neoplasms: genetic alterations, growth in vivo and the relationship of adenoviral mediated gene transfer to coxsackie adenovirus receptor expression.

  2006cited by this paper
• Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis.

  2006cited by this paper
• Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

  2006cited by this paper
• Urothelial tumorigenesis: a tale of divergent pathways

  2005cited by this paper
• Tissue Inhibitor of Metalloproteinases-3 (TIMP-3) Is a Binding Partner of Epithelial Growth Factor-containing Fibulin-like Extracellular Matrix Protein 1 (EFEMP1)

  2004cited by this paper
• Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin.

  2003cited by this paper
• Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin

  2002cited by this paper
• In silico prediction of protein-protein interactions in human macrophages

  2001cited by this paper
• Routine follow-up cystoscopy in detection of recurrence in patients being monitored for bladder cancer.

  2001cited by this paper
• p53 mutations in bladder carcinoma cell lines.

  1994cited by this paper
• Characterization of the affinities of insulin-like growth factor (IGF)-binding proteins 1-4 for IGF-I, IGF-II, IGF-I/insulin hybrid, and IGF-I analogs.

  1993cited by this paper
• Cancer statistics

  1989cited by this paper
• Overview of treatment of superficial bladder cancer.

  1986cited by this paper
• Antibiotic usage patterns: resistance and other considerations.

  1985cited by this paper

• Single-cell RNA sequencing identifies potential critical prognostic biomarkers in bladder carcinoma

  2025cites this paper
• LOC100506691 Is an Oncogenic Long Noncoding RNA that Promotes Growth and Motility of Lung Cancer Cells

  2025cites this paper
• Development of a stemness-related prognostic index to provide therapeutic strategies for bladder cancer

  2024cites this paper
• The Prognostic Importance of Expressions of FBLN2 and Microsatellit Instability (MSH2, MSH6, MLH1, PMS2) Immunhistochemical Biomarkers in Upper Urinary Tract Urothelial Cell Carcinomas

  2024cites this paper
• Preclinical models of bladder cancer: BBN and beyond

  2024cites this paper
• A Pilot Urinary Proteome Study Reveals Widespread Influences of Circadian Rhythm Disruption by Sleep Deprivation

  2023cites this paper
• Fibulin-3 as a Biomarker of Pleuric Involvement by Exposure to Fibers

  2023cites this paper
• Impact of Green Gold Nanoparticle Coating on Internalization, Trafficking, and Efficiency for Photothermal Therapy of Skin Cancer

  2023cites this paper
• Significance of fibulin-3 expression in bladder cancer: a tissue microarray-based immunohistochemical study

  2022cites this paper
• Application of Metabolic Reprogramming to Cancer Imaging and Diagnosis

  2022cites this paper
• The extracellular matrix protein fibulin-3/EFEMP1 promotes pleural mesothelioma growth by activation of PI3K/Akt signaling

  2022cites this paper
• Classical epithelial-mesenchymal transition (EMT) and alternative cell death process-driven blebbishield metastatic-witch (BMW) pathways to cancer metastasis

  2022cites this paper
• Characterizing molecular subtypes of high-risk non-muscle-invasive bladder cancer in African American patients.

  2022cites this paper
• Single-Cell Transcriptome Comparison of Bladder Cancer Reveals Its Ecosystem

  2022cites this paper
• Small extracellular vesicles in cancer

  2021cites this paper
• Experimental conditions influence the formation and composition of the corona around gold nanoparticles

  2021cites this paper
• Transport of Vitamin C in Cancer

  2021cites this paper
• Metabolomics, Transcriptomics and Functional Glycomics Reveals Bladder Cancer Cells Plasticity and Enhanced Aggressiveness Facing Hypoxia and Glucose Deprivation

  2021cites this paper
• Loss of polarity protein Par3, via transcription factor Snail, promotes bladder cancer metastasis

  2021cites this paper
• Metformin inhibits gastric cancer cell proliferation by regulation of a novel Loc100506691-CHAC1 axis

  2021cites this paper
• METTL1‐m7G‐EGFR/EFEMP1 axis promotes the bladder cancer development

  2021cites this paper
• Regulation of Glucose Transporters in Cancer Progression

  2021cites this paper
• TP63 isoform expression is linked with distinct clinical outcomes in cancer

  2020cites this paper
• EFEMP1 as a Potential Biomarker for Diagnosis and Prognosis of Osteosarcoma

  2020cites this paper
• Loss of DUSP2 predicts a poor prognosis in patients with bladder cancer.

  2019cites this paper
• In vitro functional studies of the tumour vascular target PCDH7 and identification of novel tumour vascular targets in colorectal cancer

  2019cites this paper
• Helical Self-Assembly of Optically Active Glycoconjugated Phthalocyanine J-Aggregates.

  2019cites this paper
• Involvement of Extracellular Vesicles in Vascular-Related Functions in Cancer Progression and Metastasis

  2019cites this paper
• Metformin Treatment Suppresses Melanoma Cell Growth and Motility through Modulation of microRNA Expression

  2019cites this paper
• Fibulin-3 Has Anti-Tumorigenic Activities in Cutaneous Squamous Cell Carcinoma.

  2019cites this paper
• A surgical orthotopic approach for studying the invasive progression of human bladder cancer

  2019cites this paper
• ATDC Mediates a TP63-Regulated Basal Cancer Invasive Program

  2019cites this paper
• Transcriptome reprogramming by cancer exosomes: identification of novel molecular targets in matrix and immune modulation

  2018cites this paper
• Fibulin-3 Attenuates Phosphate-Induced Vascular Smooth Muscle Cell Calcification by Inhibition of Oxidative Stress

  2018cites this paper
• Ovarian Cancer Relies on Glucose Transporter 1 to Fuel Glycolysis and Growth: Anti-Tumor Activity of BAY-876

  2018cites this paper
• Glucose transporters in cancer – from tumor cells to the tumor microenvironment

  2018cites this paper
• The matrix protein Fibulin-3 promotes KISS1R induced triple negative breast cancer cell invasion

  2018cites this paper
• Microdevices for Non-Invasive Detection of Bladder Cancer

  2017cites this paper